Signal cell seqencing of primary HCMV infections
Signal cell seqencing of primary HCMV infections
批准号:
10358609
负责人:
TIMOTHY F KOWALIK
金额:
$20.94万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-01 至 2023-02-28
关键词:
3-DimensionalAcquired Immunodeficiency SyndromeAcuteAdolescentAntigensAntiviral AgentsBiological ModelsBreast FeedingCell Differentiation processCell physiologyCellsCessation of lifeCongenital AbnormalityCytomegalovirusCytomegalovirus InfectionsDevelopmentDiscipline of NursingDiseaseEpithelial CellsEventFetusFibroblastsGanciclovirGene ExpressionGeneticHematopoietic stem cellsHerpesviridaeHumanHuman MilkImmuneImmune responseImmunologic Deficiency SyndromesIn VitroIndividualInfectionInnate Immune ResponseInterventionKnowledgeLactationMediatingMethodologyMorbidity - disease rateMothersNursing infantOpportunistic InfectionsOralOral cavityOrganPatientsPlasmaPregnant WomenPrimary InfectionProtocols documentationRiskSensorineural Hearing LossSevere Combined ImmunodeficiencySignal TransductionSolidSourceSpontaneous abortionSwabTechnologyTeratogensTestingTissue ModelTissuesTransplant RecipientsUmbilical Cord Blood TransplantationVaccinesVertical Disease TransmissionViral GenesVirusVirus ReplicationVirus SheddingWomanacquired immunodeficiencycell typeclinically relevantcongenital infectiondata analysis pipelinefetus at riskimprovedin uteroin vivoinfection rateinfluenza infectioninsightmortalitynoveloral cavity epitheliumoral infectionpathogenpreventresponsesingle cell sequencingsingle-cell RNA sequencingthree dimensional cell culturetooltranscriptometransmission processviral resistance
中文摘要
人巨细胞病毒(HCMV)是一种常见于人类的疱疹病毒。HCMV感染是终身的,通常对宿主没有明显的负担。在具有自然或获得性免疫缺陷的个体中,HCMV可能是疾病甚至死亡的重要原因。HCMV也是导致出生缺陷的主要传染病。病毒如何感染新宿主(原发感染)尚不清楚,特别是在护理期间发生的传播。hcmv阳性的哺乳期妇女- - -在全球范围内代表了大多数妇女- - -在母乳中传播病毒。大约每10名携带HCMV的妇女中就有4人会将病毒传染给正在哺乳的婴儿。这种传播是如何发生的,以及口腔中被感染的细胞的身份,人们知之甚少。在这里,我们采用尖端的单细胞RNA测序技术来识别哺乳婴儿口腔中感染的细胞,并在单个细胞的基础上确定这种感染的后果。这种方法允许我们提出一个假设,即HCMV在口腔原发性感染期间优先感染上皮细胞亚群,从而影响复制和宿主先天反应。我们将从两个方面来检验这一假设。首先,将单细胞RNA测序技术应用于HCMV感染的3D口腔上皮组织培养。第二个目标将应用该技术来分析哺乳婴儿口腔的原发性感染。这些新颖的研究将提供关于HCMV原发性感染的新知识,并为开发预防HCMV传播的改进干预措施提供信息。
英文摘要
Human cytomegalovirus (HCMV) is a herpesvirus commonly found in humans. HCMV infections are lifelong and usually do not have an apparent burden on the host. In individuals with natural or acquired immunodeficiency, HCMV can be a significant cause of disease and even death. HCMV is also the leading infectious cause of birth defects. How the virus infects a new host (primary infection) is poorly understood, especially in transmissions that occur during nursing. Lactating women who are positive for HCMV—which, globally, represents most women—shed virus in breast milk. About 4 in 10 women with HCMV will transmit the virus to their nursing infant. How this transmission occurs and the identity of cells in the oral cavity that become infected are poorly understood. Here we adapt cutting edge single cell RNA sequencing technology to identify which cells are infected in the oral cavity of nursing infants and determine the consequences of this infection on an individual cell basis. This approach allows us to propose a hypothesis that HCMV preferentially infects subsets of epithelial cells during oral primary infections that impact replication and host innate responses. We will test this hypothesis across two aims. The first, will adapt the single cell RNA sequencing technology to HCMV infected cultures of 3D oral epithelia tissues. The second aim will apply the technology to analyze primary infections in the oral cavity of nursing infants. These novel studies will provide new knowledge into HCMV primary infections and inform the development of improved interventions that prevent HCMV transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HCMV receptors, signaling and entry
-
批准号:10669505
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2022
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Signal cell seqencing of primary HCMV infections
-
批准号:10218861
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2021
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
CMV meeting support
-
批准号:8130117
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2011
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
12th International Cytomegalovirus and Beta-Herpesvirus Workshop
-
批准号:7675912
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7459591
-
项目类别:
-
资助金额:$39.24万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:8090262
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7898886
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7320328
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
Cytomegalovirus and Nuclear Tumor Suppressors
-
批准号:7650326
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2007
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6706278
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6628465
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6497996
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6350444
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
E2F AND APOPTOSIS
-
批准号:6097365
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2000
-
负责人:TIMOTHY F KOWALIK
-
依托单位:
海外基金